1. [P2–048]: AN APPROACH TO DISCOVER NOVEL MUSCARINIC M1 RECEPTOR‐POSITIVE ALLOSTERIC MODULATORS WITH POTENT COGNITIVE IMPROVEMENT AND MINIMIZED GASTROINTESTINAL DYSFUNCTION. (1st July 2017) Authors: Kurimoto, Emi; Matsuda, Satoru; Shimizu, Yuji; Sako, Yuu; Mandai, Takao; Sugimoto, Takahiro; Sakamoto, Hiroki; Kimura, Haruhide Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 12 Page Start: P623 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. [P2–051]: IN VITRO CHARACTERIZATION OF TAK‐071: A NOVEL MUSCARINIC M1 RECEPTOR‐POSITIVE ALLOSTERIC MODULATOR WITH LOW COOPERATIVITY. (1st July 2017) Authors: Kimura, Haruhide; Shimizu, Yuji; Suzuki, Atsushi; Kurimoto, Emi; Mandai, Takao; Yamada, Masami; Sako, Yuu Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 12 Page Start: P624 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Design, synthesis, and pharmacological evaluation of 4-azolyl-benzamide derivatives as novel GPR52 agonists. Issue 12 (15th June 2017) Authors: Tokumaru, Kazuyuki; Ito, Yoshiteru; Nomura, Izumi; Nakahata, Takashi; Shimizu, Yuji; Kurimoto, Emi; Aoyama, Kazunobu; Aso, Kazuyoshi Journal: Bioorganic & medicinal chemistry Issue: Volume 25:Issue 12(2017) Page Start: 3098 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Therapeutic potential of TAK-071, a muscarinic M1 receptor positive allosteric modulator with low cooperativity, for the treatment of cognitive deficits and negative symptoms associated with schizophrenia. (1st November 2021) Authors: Kurimoto, Emi; Yamada, Ryuji; Hirakawa, Takeshi; Kimura, Haruhide Journal: Neuroscience letters Issue: Volume 764(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. T‐495, a novel low cooperative M1 receptor positive allosteric modulator, improves memory deficits associated with cholinergic dysfunction and is characterized by low gastrointestinal side effect risk. Issue 1 (28th January 2020) Authors: Mandai, Takao; Sako, Yuu; Kurimoto, Emi; Shimizu, Yuji; Nakamura, Minoru; Fushimi, Makoto; Maeda, Ryouta; Miyamoto, Maki; Kimura, Haruhide Journal: Pharmacology research & perspectives Issue: Volume 8:Issue 1(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗